[:no]NCGCs anbefalinger presentert for Høie[:en]NCGC presents their recommendation to the Minister of Health[:]

by Ola Myklebost · Published 6. March 2019 · Updated 8. March 2019

[:no][et_pb_section admin_label=”Seksjon” fullwidth=”on” specialty=”off”][et_pb_fullwidth_post_title admin_label=”Fullbreddes innleggstittel” title=”on” meta=”off” author=”on” date=”on” categories=”on” comments=”on” featured_image=”on” featured_placement=”background” parallax_effect=”off” parallax_method=”on” text_orientation=”right” text_color=”light” text_background=”on” text_bg_color=”rgba(21,150,137,0.9)” module_bg_color=”rgba(255,255,255,0)” title_font=”|on|||” title_font_size=”35px” title_all_caps=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid” module_id=”header-image-and-text”]
[/et_pb_fullwidth_post_title][/et_pb_section][et_pb_section admin_label=”Seksjon” fullwidth=”off” specialty=”off”][et_pb_row admin_label=”Rad”][et_pb_column type=”2_3″][et_pb_text admin_label=”Tekst” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]

Ragnhild A Lothe, Per Eystein Lønning, Bjørn Tore Gjertsen og Ola Myklebost presenterte våre anbefalinger for hvordan Helsedepartementet i sin satsing på persontilpasset medisin kan bygge videre på vår nasjonale plattform. Vi poengterte at kreft er en svært kompleks sykdom med stort pasientvolum og krever et eget solid og tverrfaglig faglig nettverk for en fornuftig innføring i helsevesenet. Genombasert diagnostikk og behandling vil lenge være svært forskningsbasert og det vil ta tid før dette er nyttig for de fleste pasienter, men det er avgjørende viktig at metodene tas i bruk og kompetanse og erfaring etableres i helsevesenet. Vi anbefaler en nasjonal genomikkplattform for kreft, med noder i alle regioner, og koblet til et nasjonalt fagråd for kreftgenomikk, som sammen med de nasjonale kreftgruppene kan etablere og utvikle en fornuftig og bærerkraftig bruk av disse metodene tilpasset de mange ulike pasientgruppene med behov for ulike metoder og tilsvarende behandlinger.

[/et_pb_text][/et_pb_column][et_pb_column type=”1_3″][et_pb_sidebar admin_label=”Nyhetsarkiv og konferanser” orientation=”left” area=”primary” background_layout=”light” remove_border=”off”]
[/et_pb_sidebar][/et_pb_column][/et_pb_row][/et_pb_section][:en][et_pb_section admin_label=”Seksjon” fullwidth=”on” specialty=”off”][et_pb_fullwidth_post_title admin_label=”Fullbreddes innleggstittel” title=”on” meta=”off” author=”on” date=”on” categories=”on” comments=”on” featured_image=”on” featured_placement=”background” parallax_effect=”off” parallax_method=”on” text_orientation=”right” text_color=”light” text_background=”on” text_bg_color=”rgba(21,150,137,0.9)” module_bg_color=”rgba(255,255,255,0)” title_font=”|on|||” title_font_size=”35px” title_all_caps=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid” module_id=”header-image-and-text”]
[/et_pb_fullwidth_post_title][/et_pb_section][et_pb_section admin_label=”Seksjon” fullwidth=”off” specialty=”off”][et_pb_row admin_label=”Rad”][et_pb_column type=”2_3″][et_pb_text admin_label=”Tekst” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]

Ragnhild A Lothe, Per Eystein Lønning, Bjørn Tore Gjertsen and Ola Myklebost presented our recommendations on how the the prioritised effort by the Ministry on personalised medicine can build on our national genomics platform. We pointed out that cancer is a very complex disease with a large number of patients and requires a solid multidisciplinary network for clinical implementation. genome-based diagnostics and treatment will remain research-based for a long time, and better understanding is required before these strategies will benefit most patients, but it is absolutely necessary that the methods are established in the Health service, competence is built and experience is gained. We recommend a national cancer genome platform with regional nodes, linked to a national tumour board that works with our national cancer groups. This platform and network can establish and further develop knowledge-based and sustainable protocols for how these strategies can be adapted to each patient group.

Les Høies budskap om persontilpasset medisin i Sykehustalen 2019.